Nexabiome Limited (SC373464): administration
- Status
- Administration ended
- Administration began
- 2025-05-01
- Administrators
- Stuart Preston, Julie Tait
- Administrators' firm
- Grant Thornton
- Formerly
- Fixed Phage Limited
- Incorporated
- 2010-02-23
- Location
- Glasgow
- Industry
- 72190 Other research and experimental development on natural sciences and engineering
Why it went into administration
- Funding withdrawn / unable to refinance
- Sustained trading losses
From the administrators' statement
Nature of the Company’s business
The Company was incorporated in Scotland on 23 February 2010 as Fixed Phage Limited, subsequently changing its name to NexaBiome Limited in August 2023. It is a privately held R&D biotechnology company, originally incorporated as a spin-out from the University of Strathclyde.
The Company was formed to commercialise innovative research in the field of bacteriophage technology, as an alternative to antibiotics in the treatment of bacterial infections. The Company has been developing proprietary technology focused on enabling the covalent immobilisation of bacteriophages onto a wide range of substrates, improving their stability and facilitating patent protection. This addresses several traditional limitations that have hindered the widespread commercialisation of phage therapies, including short shelf-life, limited delivery formats, and IP barriers.
Administrators' statement of proposals (2025-05-08) · Companies House register